Dados B3 › POSI3 × OIBR3
POSI3 × OIBR3
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | POSI3 | OIBR3 | year |
|---|---|---|---|
| ROE | 18.3% | -243.5% | 2021 |
| ROIC | 29.5% | -91.3%! | 2022 |
| ROA | 1.9% | 41.9%! | 2024 |
| Gross margin | 25.1% | -45.7%! | 2024 |
| EBIT margin | 8.4% | -61.5%! | 2024 |
| Net margin | 2.3% | 302.2%! | 2024 |
| Net debt/EBITDA | 1.57x | 11.73x | 2021 |
| Current ratio | 1.97x | 1.00x! | 2024 |
| Revenue growth (1y) | -6.1% | -25.3%! | 2024 |
| Revenue growth (5y CAGR) | 14.0% | -21.2%! | 2024 |
| Piotroski F-Score | 5/9 | 5/9! | 2024 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | POSI3 | OIBR3 | year |
|---|---|---|---|
| P/E | 71.88x | 0.00x | 2025 × 2024 |
| P/B | 0.39x | — | 2025 × 2024 |
| EV/EBITDA | 4.08x | — | 2025 × 2024 |
| FCF yield | 24.3% | -352,559.1% | 2025 × 2024 |
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 10:04 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 10:04 UTC. If this does not match /saude, you are reading a cached copy.